Foundational Science and Mechanisms of Disease

A 24-year-old healthy man sustains a superficial laceration to his left index finger while preparing food. Minor bleeding occurs but completely ceases within a few minutes. This normal physiological response involves a highly coordinated series of vascular, cellular, and protein-mediated events. Arrange the following steps of the normal hemostatic process in the correct chronological order, beginning immediately after the initial endothelial disruption.

Match each patient's clinical presentation with the primary immunopathogenic mechanism underlying their disease.

A 28-year-old man comes to the clinic with a painful, swollen, and red area on his right forearm. The lesion has been progressively worsening over the past 3 days. He has a history of injection drug use. Physical examination reveals a 4-cm erythematous, fluctuant nodule with surrounding induration and warmth. The abscess is incised and drained, yielding thick, purulent material. A Gram stain of the exudate shows Gram-positive cocci in clusters. The patient is prescribed oral cephalexin and discharged. Two days later, he returns to the emergency department with expanding erythema extending up to his elbow, worsening pain, and a new fever of 38.6°C (101.5°F). Subsequent culture results confirm the presence of an organism that is resistant to oxacillin. Which of the following best describes the molecular mechanism responsible for this pathogen's resistance to the initial outpatient antibiotic therapy?

A physician is reviewing medication safety protocols for a hospital's Pharmacy and Therapeutics Committee. Various clinical scenarios are presented that highlight critical alterations in pharmacokinetics, requiring specific dosing strategies or medication substitutions to prevent severe adverse events. Match each high-risk clinical scenario with its primary underlying pharmacokinetic mechanism.

A 32-year-old man comes to the clinic due to a 4-week history of severe, crampy abdominal pain and 5 to 7 bloody bowel movements per day. He also reports tenesmus and a 3-kg (6.6-lb) weight loss during this time. His medical history is significant for severe plaque psoriasis that was refractory to high-potency topical corticosteroids and narrowband ultraviolet B phototherapy. Five months ago, his dermatologist initiated a new targeted biologic therapy, which has resulted in near-complete clearance of his skin lesions. His temperature is 37.8°C (100.0°F), pulse is 98/min, and blood pressure is 118/76 mm Hg. Physical examination shows a soft abdomen with moderate tenderness in the left lower quadrant. No cutaneous plaques are visible. Flexible sigmoidoscopy reveals continuous mucosal erythema, edema, friability, and loss of the normal vascular pattern extending from the anal verge to the splenic flexure. Which of the following describes the mechanism of action of the pharmacologic agent most likely responsible for this patient's current gastrointestinal condition?

Match each patient's clinical presentation with the primary molecular mechanism by which the causative pathogen survives within host cells.

An oncologist requests a consultation in the emergency department for a 67-year-old woman complaining of frequent, voluminous, non-bloody diarrhea. She was diagnosed with advanced non-small cell lung cancer four months ago and recently completed her third cycle of cemiplimab therapy. She reports up to 10 bowel movements daily, accompanied by diffuse abdominal cramping, but denies fever, sick contacts, or recent antibiotic use. Vital signs are stable. Physical examination reveals mild lower abdominal tenderness without guarding or rebound. Laboratory studies show mild hypokalemia and a normal white blood cell count. Stool testing for Clostridioides difficile toxin and routine enteric pathogens is negative. Flexible sigmoidoscopy demonstrates diffuse mucosal erythema, loss of vascular pattern, and ulceration. Biopsy reveals dense cytotoxic T-lymphocytic infiltrates in the lamina propria with crypt abscesses. The pathogenesis of this patient's current gastrointestinal condition is most directly linked to pharmacological interference with which of the following immunologic mechanisms?

A $45$-year-old man is evaluated following a screening colonoscopy that revealed a $4\text{-cm}$ ulcerated mass in the ascending colon. He has no significant past medical history. His family history is notable for a father who died of colon cancer at age $50$ and a paternal aunt who was diagnosed with endometrial cancer at age $48$. Biopsy of the colonic mass confirms invasive adenocarcinoma. Immunohistochemical staining of the tumor specimen demonstrates an absence of nuclear staining for MLH1 and PMS2 proteins, while MSH2 and MSH6 proteins maintain normal nuclear expression. Further molecular analysis of the tumor reveals wild-type $BRAF$ and high microsatellite instability (MSI-H). Based on the underlying molecular pathogenesis of this patient's neoplasm, which of the following is the most appropriate next step in management?

A 55-year-old man comes to the clinic for a follow-up visit. He has a history of major depressive disorder and hypertension. His medications include paroxetine, which he has been taking for 2 years with excellent symptom control. Two weeks ago, his primary care physician started him on metoprolol succinate for poorly controlled blood pressure. Today, the patient reports severe fatigue, lightheadedness, and episodes of feeling "close to passing out" when standing up quickly. Vital signs show a blood pressure of 98/60 mm Hg and a pulse of 44/min. Physical examination is unremarkable except for bradycardia. An electrocardiogram shows sinus bradycardia with no other abnormalities. Which of the following pharmacokinetic or pharmacodynamic interactions best explains this patient's current presentation?

A 65-year-old man with a history of a mechanical aortic valve replacement is hospitalized for a 2-week history of low-grade fever, fatigue, and night sweats. Physical examination reveals a new diastolic murmur and splinter hemorrhages on his fingernails. Multiple sets of blood cultures grow Enterococcus faecalis. Antimicrobial susceptibility testing indicates that the isolate is susceptible to ampicillin but exhibits high-level resistance to gentamicin (minimum inhibitory concentration > 500 µg/mL). The infectious disease team determines that the standard ampicillin and gentamicin synergistic combination will not be effective. Which of the following is the most likely molecular mechanism underlying this pathogen's resistance to the aminoglycoside?

For each patient presenting with a distinct hemorrhagic or thrombotic disorder, select the primary underlying pathophysiologic mechanism.

A 54-year-old woman is admitted to the intensive care unit for a severe exacerbation of chronic obstructive pulmonary disease. She is started on a continuous intravenous infusion of theophylline. After 48 hours, her plasma theophylline concentration reaches a steady state of $8 \text{ mg/L}$. To aggressively optimize bronchodilation, the intensivist triples the infusion rate. Simultaneous with this rate increase, the patient is diagnosed with a suspected multidrug-resistant infection, and rifampin, a potent cytochrome P450 inducer, is added to her regimen. Pharmacokinetic analysis indicates that rifampin therapy will precisely double the hepatic clearance of theophylline without altering its volume of distribution.

If the new, tripled theophylline infusion rate is maintained, which of the following accurately describes the patient's new theophylline steady-state concentration and the time required to reach it (compared to the original time to reach steady state)?

A 48-year-old man with severe, refractory rheumatoid arthritis is treated with an intravenous infusion of a chimeric monoclonal antibody. Twelve days after the infusion, he presents to the urgent care clinic with a new-onset pruritic rash, spiking fevers, and severe joint pain in his knees and wrists. Laboratory testing shows reduced serum C3 and C4 levels, an elevated erythrocyte sedimentation rate, and new-onset proteinuria. Arrange the following immunopathologic events in the correct chronological sequence that led to this patient's current clinical presentation.

A 42-year-old agricultural worker is evaluated in the emergency department for progressive jaw stiffness, difficulty swallowing, and painful muscle spasms. Two weeks ago, he sustained a deep puncture wound to his left foot from a rusty nail while working in the field and did not seek medical care. Physical examination reveals marked trismus and spasms of the facial muscles, producing a fixed smile. The physician suspects an infection by a spore-forming, Gram-positive, obligate anaerobic bacillus. Arrange the following steps in the pathophysiologic cascade of this disease process in chronological order, from initial toxin entry to the final molecular mechanism causing the patient's symptoms.

A $65$-year-old man is hospitalized for treatment of methicillin-resistant *Staphylococcus aureus* (MRSA) osteomyelitis. For the past week, he has been receiving a continuous intravenous infusion of a novel antimicrobial agent at a rate of $40$ mg/hr. His renal and hepatic functions have remained stable. Routine therapeutic drug monitoring reveals a steady-state plasma concentration of $8$ mg/L.

The patient is now clinically stable and is being prepared for discharge to complete a prolonged course of therapy. The infectious disease specialist recommends transitioning the patient to an oral formulation of the same medication. To ensure adequate bone penetration for the remainder of the therapy, the specialist also recommends targeting a higher average steady-state plasma concentration of $12$ mg/L.

The oral formulation of this medication has a known bioavailability of $60\%$ ($F = 0.60$). The planned dosing interval for the oral regimen is every $8$ hours.

Assuming the patient's pharmacokinetic parameters remain constant, what oral dose (in mg) should be administered every $8$ hours to achieve the new target concentration?

A 41-year-old woman is brought to the emergency department by her partner due to progressive confusion, fatigue, and the appearance of small red spots on her legs over the past three days. Her medical history is unremarkable, and she takes no medications. Vital signs are temperature 38.2°C (100.8°F), blood pressure 145/88 mmHg, heart rate 112/min, and respiratory rate 18/min. Physical examination reveals scleral icterus, diffuse petechiae over the lower extremities, and disorientation to time and place.

Initial laboratory studies show:
- Hemoglobin: 7.6 g/dL
- Platelet count: 22,000/mm³
- Leukocyte count: 8,500/mm³
- Creatinine: 1.4 mg/dL
- Total bilirubin: 3.2 mg/dL (Indirect: 2.8 mg/dL)
- Prothrombin time (PT): 12 seconds
- Activated partial thromboplastin time (aPTT): 28 seconds

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for managing this patient's condition.

A 64-year-old man is evaluated in the hospital prior to the planned placement of a tunneled hemodialysis catheter. He has a history of end-stage renal disease secondary to diabetic nephropathy and currently receives hemodialysis via a temporary right internal jugular venous catheter. Over the past 48 hours, the nursing staff has noted persistent oozing of blood from the catheter insertion site. His current medications include amlodipine, sevelamer, and erythropoietin. Vital signs are within normal limits. Laboratory studies reveal the following:

Which of the following is the most appropriate pharmacologic intervention to reduce this patient's bleeding risk before the upcoming procedure?

A pediatric immunology clinic evaluates several patients with suspected primary immunodeficiencies. For each patient profile below, identify the primary immunopathologic mechanism responsible for their disease.

A retired teacher with longstanding nonvalvular atrial fibrillation is brought to the emergency department by ambulance following an episode of syncope and large volume melena. He is 74 years old and has been successfully managed on a stable dose of dabigatran for the past three years. His past medical history is also significant for hypertension, for which he takes lisinopril and metoprolol. Two weeks prior to presentation, he was diagnosed with widespread onychomycosis by a dermatologist and was prescribed a three-month course of oral itraconazole. Upon arrival, his blood pressure is $88/54\text{ mmHg}$, and his heart rate is $115\text{/min}$. Initial laboratory evaluation reveals a hemoglobin concentration of $6.8\text{ g/dL}$ and a significantly prolonged activated partial thromboplastin time. Which of the following pharmacokinetic or pharmacodynamic mechanisms most accurately explains the adverse event observed in this patient?

A 58-year-old man is hospitalized in the intensive care unit for the management of severe necrotizing pancreatitis. On hospital day 14, he develops new-onset fever, copious purulent endotracheal secretions, and worsening hypoxemia. He is intubated and requires mechanical ventilation. A Gram stain of the endotracheal aspirate reveals numerous polymorphonuclear leukocytes and Gram-negative bacilli. The culture grows a strictly aerobic, oxidase-positive organism. Susceptibility testing demonstrates that the isolate is highly susceptible to imipenem, cefepime, ciprofloxacin, and tobramycin. The patient is started on intravenous imipenem. After 10 days of therapy, his respiratory status declines again. A repeat endotracheal culture grows the same organism, but a new susceptibility panel reveals resistance to imipenem, while remaining susceptible to cefepime, ciprofloxacin, and tobramycin. Which of the following molecular mechanisms best explains the newly acquired antimicrobial resistance profile in this patient's isolate?